MeSH Browser

MeSH Heading: Hemibody Irradiation
Tree Number(s): E02.815.270
Unique ID: D017619
RDF Unique Identifier: http://id.nlm.nih.gov/mesh/D017619
Annotation: in radiotherapy, coordinate with disease /‌radiother; for hemibody irradiation experiments, coordinate with organ or process /‌rad eff
Scope Note: Irradiation of one half or both halves of the body in the treatment of disseminated cancer or widespread metastases. It is used to treat diffuse metastases in one session as opposed to multiple fields over an extended period. The more frequent treatment modalities are upper hemibody irradiation (UHBI) or lower hemibody irradiation (LHBI). Less common is mid-body irradiation (MBI). In the treatment of both halves of the body sequentially, hemibody irradiation permits radiotherapy of the whole body with larger doses of radiation than could be accomplished with WHOLE-BODY IRRADIATION. It is sometimes called systemic hemibody irradiation with reference to its use in widespread cancer or metastases. (P. Rubin et al. Cancer, Vol 55, p2210, 1985)
Entry Version: HEMIBODY IRRAD
Entry Term(s): Half-Body Irradiation; Hemi-Body Irradiation; Irradiation, Half-Body; Irradiation, Hemibody; Sequential Hemibody Irradiation; Systemic Hemibody Irradiation
Previous Indexing: Radiotherapy (1980-1993); Radiotherapy Dosage (1980-1993); Whole-Body Irradiation (1981-1993)
See Also: Whole-Body Irradiation
Public MeSH Note: 94
History Note: 94
Date Established: 1994/01/01
Date of Entry: 2024/11/06
Revision Date: 2024/11/06

Allowable Qualifiers: adverse effects (AE)

classification (CL)

economics (EC)

ethics (ES)

history (HI)

instrumentation (IS)

methods (MT)

mortality (MO)

nursing (NU)

psychology (PX)

standards (ST)

statistics & numerical data (SN)

trends (TD)

veterinary (VE)

Therapeutics [E02]
- Radiotherapy [E02.815]

Hemibody Irradiation Preferred

Concept UI: M0026690
Scope Note: Irradiation of one half or both halves of the body in the treatment of disseminated cancer or widespread metastases. It is used to treat diffuse metastases in one session as opposed to multiple fields over an extended period. The more frequent treatment modalities are upper hemibody irradiation (UHBI) or lower hemibody irradiation (LHBI). Less common is mid-body irradiation (MBI). In the treatment of both halves of the body sequentially, hemibody irradiation permits radiotherapy of the whole body with larger doses of radiation than could be accomplished with WHOLE-BODY IRRADIATION. It is sometimes called systemic hemibody irradiation with reference to its use in widespread cancer or metastases. (P. Rubin et al. Cancer, Vol 55, p2210, 1985)
Terms: Hemibody Irradiation Preferred Term
Term UI T052811
Date01/01/1999
LexicalTag NON
ThesaurusID NLM (1994); Half-Body Irradiation
Term UI T052806
Date07/02/1992
LexicalTag NON
ThesaurusID NLM (1994); Hemi-Body Irradiation
Term UI T052812
Date07/02/1992
LexicalTag NON
ThesaurusID NLM (1994); Irradiation, Half-Body
Term UI T052807
Date07/02/1992
LexicalTag NON
ThesaurusID NLM (1994); Irradiation, Hemibody
Term UI T052810
Date07/02/1992
LexicalTag NON
ThesaurusID NLM (1994); Sequential Hemibody Irradiation
Term UI T052808
Date11/16/1992
LexicalTag NON
ThesaurusID NLM (1994); Systemic Hemibody Irradiation
Term UI T052809
Date07/02/1992
LexicalTag NON
ThesaurusID NLM (1994)

Hemibody Irradiation MeSH Descriptor Data 2025